Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE
Conway’s Law and Breaking Down Dev Team Silo With Krishna Bala
Proscia Receives FDA 510(k) Clearance For Concentriq AP-Dx
Proscia receives 510(k) clearance from FDA for digital pathology solution
Interview with Proscia CEO David West
How digital pathology can transform the value of clinical trial information
The Essential Inquiries: How Concentriq Answers Sponsors’ Most Pressing Pathology Questions for CROs
Lessons To Learn From The UK’s Pathology Challenges And Its Technology-Centric Strategy To Deliver Quality Diagnostic Services
ACSR and Proscia partnership spearheads rapid equitable distribution of real-world digital pathology data to drive HIV and cancer research
Episode 169: Amanda Coble – Embracing Opportunities And Driving Innovation At Proscia
Digitised pathology resource will speed HIV cancer R&D

Our website uses cookies. By using this site, you agree to its use of cookies.